| Unique ID issued by UMIN | UMIN000052879 |
|---|---|
| Receipt number | R000060338 |
| Scientific Title | Effects of a dairy ingredient on skin condition in healthy subjects: a randomized, double-blind, placebo-controlled trial. |
| Date of disclosure of the study information | 2023/11/23 |
| Last modified on | 2023/11/23 06:59:19 |
Effects of a dairy ingredient on skin condition in healthy subjects: a randomized, double-blind, placebo-controlled trial.
Effects of a dairy ingredient on skin condition in healthy subjects.
Effects of a dairy ingredient on skin condition in healthy subjects: a randomized, double-blind, placebo-controlled trial.
Effects of a dairy ingredient on skin condition in healthy subjects.
| Japan |
None (Healthy subjects)
| Not applicable | Adult |
Others
NO
To investigate the effects of a dairy ingredient on skin condition.
Efficacy
Index for skin conditions (Skin moisture content, Transepidermal water loss)
Feeling of dry skin.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Ingestion of dairy ingredient for 12 weeks.
Ingestion of placebo for 12 weeks.
| 30 | years-old | <= |
| 59 | years-old | >= |
Female
1)Healthy Japanese females aged 30-59 years.
2)Subjects who temporarily feel stressed due to work.
3)Subjects experiencing dry skin.
1)Subjects having a milk allergy.
2)Subjects whose lifestyle or living environment is possibly to change significantly during the study.
3)Subjects whose bedtime and/or waking time may change significantly during the study.
4)Subjects who are receiving invasive medical treatments or spa treatments impacting measured skin locations.
5)Subjects who have participated in other clinical trials within the past 3 months.
6)Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study.
7)Subjects who have serious disease in the liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, metabolic system, or have chronic disease etc. Or those who have serious medical history of these.
8)Subjects who have skin diseases, mental illness, a sleep disorder, or a medical history.
9)Subjects who needs to be on medication for allergic diseases such as pollinosis.
10)Smokers.
11)Extremely heavy drinkers (more than 60g/day of alcohol).
12)Subjects who use medicines or who habitually consume health-promoting foods.
13)Subjects who plan to engage in activities that affect skin condition at measured sites during the study.
14)Others who have been determined as ineligible for the research subject of this study, judging from the principal researcher/doctor's opinions on the findings of their background etc.
80
| 1st name | Takashi |
| Middle name | |
| Last name | Koikeda |
Shiba Palace Clinic
Hospital director
105-0013
6F Daiwa A Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo
03-5408-1599
jimukyoku@mail.souken-r.com
| 1st name | Miwa |
| Middle name | |
| Last name | Kaneko |
SOUKEN Co., Ltd.
Secretariat
105-0013
3F Daiwa A Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo
03-5408-1555
jimukyoku@mail.souken-r.com
SOUKEN Co., Ltd.
Morinaga Milk Industry Co., Ltd.
Profit organization
Shiba Palace Clinic Ethics Review Committee
6F Daiwa A Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo
03-5408-1599
jimukyoku@mail.souken-r.com
NO
| 2023 | Year | 11 | Month | 23 | Day |
Unpublished
Preinitiation
| 2023 | Year | 10 | Month | 26 | Day |
| 2023 | Year | 10 | Month | 26 | Day |
| 2023 | Year | 11 | Month | 24 | Day |
| 2024 | Year | 03 | Month | 31 | Day |
| 2023 | Year | 11 | Month | 23 | Day |
| 2023 | Year | 11 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060338